Frontlight ResearchEarly access
Trial site
Facharztzentrum Dresden-Neustadt Betriebsgesellschaft mbH
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Heart failure6 trials
- Atrial fibrillation4 trials
- Familial hypercholesterolaemia2 trials
- Obesity2 trials
- Stroke2 trials
- Aortic stenosis1 trial
- Chronic kidney disease1 trial
- High blood pressure1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 42 trials
- Status
- Recruiting6 trials
- Completed5 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim3 trials
- Novo Nordisk A/S3 trials
- Novartis Pharma AG2 trials
- Novartis Pharmaceuticals2 trials
- Amgen Inc.1 trial
- and 4 more
Running trials
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure4 recruiting
- Obesity2 recruiting
- Aortic stenosis1 recruiting
- Atrial fibrillation1 recruiting
- High blood pressure1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026